PlumX Metrics
Embed PlumX Metrics

Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings.

Journal of chemotherapy (Florence, Italy), ISSN: 1120-009X, Vol: 16 Suppl 5, Page: 44-7
2004
  • 0
    Citations
  • 0
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Article Description

Stop-flow perfusion (SFP) is a recently implemented locoregional treatment based on the vascular isolation of the tumor bearing body district through a radiointerventistic technique. SFP is currently under investigation as a palliative therapeutic option for patients with locally advanced tumors. This paper reports on the results of our prospective study of limb and pelvic SFP. Thirty-seven patients were treated with SFP. No postoperative deaths occurred. Locoregional and systemic toxicity were observed after 22 and 31 treatments, respectively; complete and partial response after 3 (6%) and 24 (51%) SFPs, respectively. The pharmacokinetic study showed that pelvic SFP was associated with a leakage rate higher than femoral SFP (38% vs 28%). In conclusion, SFP is a feasible procedure. Toxicity and tumor response rates strictly depend upon drug leakage control.

Bibliographic Details

Miotto, D; Bertolo, S; Minante, M; Darisi, T; Mocellin, S; Casara, D; Ori, C; Foletto, M; Rossi, C R; Lise, M; Nitti, D

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know